Comparison of the ability of viral protein-expressing plasmid DNAs to protect against influenza

Vaccine

Volumn 16, Issue 16, 1998, Pages 1544-1549

  Chen, Ze ^a   Sahashi, Yasuhiro ^a   Matsuo, Kazutoshi ^a   Asanuma, Hideki ^a   Takahashi, Hidehiro ^a   Iwasaki, Takuya ^a   Suzuki, Yujiro ^b   Aizawa, Chikara ^b   Kurata, Takeshi ^a   Tamura, Shin Ichi ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b KITASATO INSTITUTE   (Japan)

Author keywords

DNA vaccine; Hemagglutinin; Influenza; Neuraminidase

Indexed keywords

BETA ACTIN; DNA VACCINE; INFLUENZA VACCINE; MATRIX PROTEIN; PLASMID DNA; VIRUS HEMAGGLUTININ; VIRUS NUCLEOPROTEIN; VIRUS PROTEIN; VIRUS SIALIDASE;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; BIOLISTIC TRANSFORMATION; CONTROLLED STUDY; DRUG SYNTHESIS; EXPRESSION VECTOR; FEMALE; HUMAN; HUMAN CELL; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; INTRAMUSCULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VACCINE PRODUCTION;

ANIMALS; ANTIBODIES, VIRAL; BIOLISTICS; CHICKENS; DNA, VIRAL; HEMAGGLUTININS; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MICE; MICE, INBRED BALB C; NEURAMINIDASE; PLASMIDS; VACCINES, DNA; VIRAL PROTEINS;

EID: 19244381134     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00043-7     Document Type: Article

References (25)

1. 1 Ulmer, J.B., Donnelly, J.J., Paker, S.E., Rhodes, G.H., Felgner, P.L. and Dwarki, V.J. et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993, 259, 1745-1749.
2. 2 Fynan, E.F., Webster, R.G., Fuller, D.H., Haynes, J.R., Santoro, J.C. and Robinson, H.L. DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc. Natl Acad. Sci. U.S.A. 1993, 90, 11478-11482.
3. 3 Robinson, H.L., Hunt, L.A. and Webster, R.G. Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA. Vaccine 1993, 11, 957-960.
4. 4 Webster, R.G., Fynan, E.F., Santoro, J.C. and Robinson, H. Protection of ferrets against influenza challenge with a DNA vaccine to the haemagglutinin. Vaccine 1994, 12, 1495-1498.
5. 5 Raz, E., Carson, D.A. and Parker, S.E. et al. Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc. Natl Acad. Sci. U.S.A. 1994, 91, 9519-9523.
6. 6 Ulmer, J.B., Deck, R.R., DeWitt, C.M., Friedman, A., Donnelly, J.J. and Liu, M.A. Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines. Vaccine 1994, 12, 1541-1544.
7. 7 Pertmer, T.M., Eisenbraun, M.D., MacCabe, D., Prayaga, S.K., Fuller, D.H. and Haynes, J.R. Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA. Vaccine 1995, 13, 1427-1430.
8. 8 Donnelly, J.J., Friedman, A., Martinez, D., Montgomery, D.L., Shiver, J.W., Motzel, S.U., Ulmer, J.B. and Liu, M.A. Preclinical efficacy of a prototype DNA vaccine enhanced protection against antigenic drift in influenza virus. Natl Med. 1995, 1, 583-587.
9. 9 Niwa, H., Yamamura, K. and Miyazaki, J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991, 108, 193-200.
10. 10 Tamura, S.-I., Miyata, K., Matsuo, K., Asanuma, H., Takahashi, H., Nakajima, K., Suzuki, Y., Aizawa, C. and Kurata, T. Acceleration of influenza virus clearance by Th1 cells in the nasal site of mice immunized intranasally with adjuvant-combined recombinant nucleoprotein. J. Immunol. 1996, 156, 3892-3900.
11. 11 Yetter, R.A., Lehrer, S., Ramphal, R. and Small, P.A. Jr. Outcome of influenza infection: effect of site of initial infection and heterotypic immunity. Infect. Immun. 1980, 29, 654-662.
12. 12 Tamura, S.-I., Ito, Y., Asanuma, H., Hirabayashi, Y., Suzuki, Y., Nagamine, T., Aizawa, C. and Kurata, T. Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit. J. Immunol. 1992, 149, 981-988.
13. 13 Phelan, M.A., Mayner, R.E., Bucker, DJ. and Ennis, F.A. Purification of influenza virus glycoproteins for the preparation and standardization of immunological potency testing reagents. J. Biol. Standard. 1980, 8, 233-242.
14. 14 Poitier, M., Mameli, L., Belisle, M., Dallaire, L. and Melancon, S.B. Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-α-D-acetylneuraminate) substrate. Anal. Biochem. 1979, 94, 287-296.
15. 15 Deroo, T., Jou, W.M. and Fiers, W. Recombinant neuraminidase vaccine protects against lethal influenza. Vaccine 1996, 14, 561-569.
16. 16 Davenport, F.M., Hennessy, A.V., Brandon, F.M., Webster, R.G., Barrett, C.D. Jr. and Lease, G.O. Comparison of serologic and febrile responses in humans to vaccination with influenza A viruses or their hemagglutinins. J. Lab. Clin. Med. 1964, 63, 5-13.
17. 17 Tobita, K., Sugiura, A., Enomoto, C. and Furuyama, M. Plaque assay and primary isolation of influenza A viruses in an established line of canine kidney cells (MDCK) in the prosence of trypsin. Med. Microbiol. Immunol. 1975, 162, 9-14.
18. 18 Epstein, S.L., Misplon, J.A., Lawson, C.M., Subbarao, E.K., Connors, M. and Murphy, M.D. Beta 2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase. J Immunol. 1993, 150, 5484-5493.
19. 19 Johansson, B.E. and Kilbourne, E.D. Immunization with purified N1 and N2 influenza virus neuraminidases demonstrates cross-reactivity without antigenic competion. Proc. Natl Acad. Sci. U.S.A. 1994, 91, 2358-2361.
20. 20 Johansson, B.E. and Kilbourne, E.D. Immunization with dissociated neuraminidase, matrix, and nucleoproteins from influenza A virus eliminates cognate help and antigenic competition. Virology 1996, 225, 136-144.
21. 21 Tamura, S.-I., Funato, H., Hirabayashi, Y., Suzuki, Y., Nagamine, T., Aizawa, C. and Kurata, T. Cross-protection aginst influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecule. Eur. J. Immunol. 1991, 21, 1337-1344.
22. 22 Tamura, S.-I., Asanuma, H., Ito, Y., Hirabayashi, H., Suzuki, Y., Nagamine, T., Aizawa, C., Kurata, T. and Oya, A. Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine. Eur. J. Immunol. 1992, 22, 477-481.
23. 23 Bender, B.S., Rowe, C.A., Taylor, S.F., Wyatt, L.S., Moss, B. and Small, P.A. Jr. Oral immunization with a replication-deficient recombinant vaccinia virus protects mice against influenza. J. Virol. 1996, 70, 6418-6424.
24. 24 Kuklin, N., Daheshia, M., Karem, K., Manickan, E. and Rouse, BT. Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization. J. Virol. 1997, 71, 3138-3145.
25. 25 Okada, E., Sasaki, S., Ishii, N., Aoki, I., Yasuda, T., Nishioka, K., Fukushima, J., Miyazaki, J., Wahren, B. and Okuda, K. Intranasal immunization of a DNA vaccine with IL-12-and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens. J. Immunol. 1997, 159, 3638-3647.